BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

792 related articles for article (PubMed ID: 35002240)

  • 1. Stem Cell Mimicking Nanoencapsulation for Targeting Arthritis.
    Shin MJ; Park JY; Lee DH; Khang D
    Int J Nanomedicine; 2021; 16():8485-8507. PubMed ID: 35002240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miRNA-146a Improves Immunomodulatory Effects of MSC-derived Exosomes in Rheumatoid Arthritis.
    Tavasolian F; Hosseini AZ; Soudi S; Naderi M
    Curr Gene Ther; 2020; 20(4):297-312. PubMed ID: 32938348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammation-Targeting Mesenchymal Stem Cells Combined with Photothermal Treatment Attenuate Severe Joint Inflammation.
    Shin MJ; Park JY; Park JY; Lim SH; Lim H; Choi JK; Park CK; Kang YJ; Khang D
    Adv Mater; 2024 Mar; 36(11):e2304333. PubMed ID: 38096399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunomodulatory Effects of Mesenchymal Stem Cells and Mesenchymal Stem Cell-Derived Extracellular Vesicles in Rheumatoid Arthritis.
    Liu H; Li R; Liu T; Yang L; Yin G; Xie Q
    Front Immunol; 2020; 11():1912. PubMed ID: 32973792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Migration of mesenchymal stem cells to tumor xenograft models and
    Kalimuthu S; Zhu L; Oh JM; Gangadaran P; Lee HW; Baek SH; Rajendran RL; Gopal A; Jeong SY; Lee SW; Lee J; Ahn BC
    Int J Med Sci; 2018; 15(10):1051-1061. PubMed ID: 30013447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homing of mesenchymal stem cells: mechanistic or stochastic? Implications for targeted delivery in arthritis.
    Eseonu OI; De Bari C
    Rheumatology (Oxford); 2015 Feb; 54(2):210-8. PubMed ID: 25288785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nano-Engineered Mesenchymal Stem Cells Increase Therapeutic Efficacy of Anticancer Drug Through True Active Tumor Targeting.
    Layek B; Sadhukha T; Panyam J; Prabha S
    Mol Cancer Ther; 2018 Jun; 17(6):1196-1206. PubMed ID: 29592881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LC-MS/MS-based serum proteomics reveals a distinctive signature in a rheumatoid arthritis mouse model after treatment with mesenchymal stem cells.
    Jung N; Park S; Kong T; Park H; Seo WM; Lee S; Kang KS
    PLoS One; 2022; 17(11):e0277218. PubMed ID: 36331907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The remodeling of ovarian function: targeted delivery strategies for mesenchymal stem cells and their derived extracellular vesicles.
    Song Y; Wu J; Liu Y; Xu N; Bai H; Wang L; Ai J; Li K
    Stem Cell Res Ther; 2024 Mar; 15(1):90. PubMed ID: 38539206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Research progress of engineered mesenchymal stem cells and their derived exosomes and their application in autoimmune/inflammatory diseases.
    Zhu X; Ma D; Yang B; An Q; Zhao J; Gao X; Zhang L
    Stem Cell Res Ther; 2023 Apr; 14(1):71. PubMed ID: 37038221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A paradigm shift in cell-free approach: the emerging role of MSCs-derived exosomes in regenerative medicine.
    Moghadasi S; Elveny M; Rahman HS; Suksatan W; Jalil AT; Abdelbasset WK; Yumashev AV; Shariatzadeh S; Motavalli R; Behzad F; Marofi F; Hassanzadeh A; Pathak Y; Jarahian M
    J Transl Med; 2021 Jul; 19(1):302. PubMed ID: 34253242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCR2-overexpressing mesenchymal stem cells targeting damaged liver enhance recovery of acute liver failure.
    Xu R; Ni B; Wang L; Shan J; Pan L; He Y; Lv G; Lin H; Chen W; Zhang Q
    Stem Cell Res Ther; 2022 Feb; 13(1):55. PubMed ID: 35123561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomes from mesenchymal stem cells overexpressing MIF enhance myocardial repair.
    Liu X; Li X; Zhu W; Zhang Y; Hong Y; Liang X; Fan B; Zhao H; He H; Zhang F
    J Cell Physiol; 2020 Nov; 235(11):8010-8022. PubMed ID: 31960418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic Potential of Mesenchymal Cell-Derived miRNA-150-5p-Expressing Exosomes in Rheumatoid Arthritis Mediated by the Modulation of MMP14 and VEGF.
    Chen Z; Wang H; Xia Y; Yan F; Lu Y
    J Immunol; 2018 Oct; 201(8):2472-2482. PubMed ID: 30224512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Mesenchymal Stem Cell-Derived Exosomes on Autoimmune Diseases.
    Shen Z; Huang W; Liu J; Tian J; Wang S; Rui K
    Front Immunol; 2021; 12():749192. PubMed ID: 34646275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of tumor growth by gene modification of mesenchymal stem cells using spermine-pullulan/DNA nanoparticles.
    Hu YL; Miao PH; Huang B; Zhang TY; Hu ZJ; Tabata Y; Gao JQ
    J Biomed Nanotechnol; 2014 Feb; 10(2):299-308. PubMed ID: 24738338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic potential of mesenchymal stem cell-derived extracellular vesicles as novel cell-free therapy for treatment of autoimmune disorders.
    Kahmini FR; Shahgaldi S
    Exp Mol Pathol; 2021 Feb; 118():104566. PubMed ID: 33160961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential applications of mesenchymal stem cells and their derived exosomes in regenerative medicine.
    Adelipour M; Lubman DM; Kim J
    Expert Opin Biol Ther; 2023; 23(6):491-507. PubMed ID: 37147781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo migration of Fe
    Li X; Wei Z; Li B; Li J; Lv H; Wu L; Zhang H; Yang B; Zhu M; Jiang J
    Biomater Sci; 2019 Jun; 7(7):2861-2872. PubMed ID: 31070196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic modification of mesenchymal stem cells overexpressing CCR1 increases cell viability, migration, engraftment, and capillary density in the injured myocardium.
    Huang J; Zhang Z; Guo J; Ni A; Deb A; Zhang L; Mirotsou M; Pratt RE; Dzau VJ
    Circ Res; 2010 Jun; 106(11):1753-62. PubMed ID: 20378860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.